{ "@context": "https://schema.org", "@type": "Organization", "name": "Brainscape", "url": "https://www.brainscape.com/", "logo": "https://www.brainscape.com/pks/images/cms/public-views/shared/Brainscape-logo-c4e172b280b4616f7fda.svg", "sameAs": [ "https://www.facebook.com/Brainscape", "https://x.com/brainscape", "https://www.linkedin.com/company/brainscape", "https://www.instagram.com/brainscape/", "https://www.tiktok.com/@brainscapeu", "https://www.pinterest.com/brainscape/", "https://www.youtube.com/@BrainscapeNY" ], "contactPoint": { "@type": "ContactPoint", "telephone": "(929) 334-4005", "contactType": "customer service", "availableLanguage": ["English"] }, "founder": { "@type": "Person", "name": "Andrew Cohen" }, "description": "Brainscape’s spaced repetition system is proven to DOUBLE learning results! Find, make, and study flashcards online or in our mobile app. Serious learners only.", "address": { "@type": "PostalAddress", "streetAddress": "159 W 25th St, Ste 517", "addressLocality": "New York", "addressRegion": "NY", "postalCode": "10001", "addressCountry": "USA" } }

Summer 25 - NMBA Flashcards

(95 cards)

1
Q

What is the mechanism of action of NMBAs?

A

Magnesium potentiates NMBAs by inhibiting calcium influx at the presynaptic terminal. NMBAs act on both presynaptic and postsynaptic nicotinic receptors to reduce acetylcholine availability and receptor activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the characteristics of mature and immature postsynaptic receptors?

A

Mature receptors are long-lived (2 weeks) and less easily depolarized. Immature receptors are short-lived (24 hours) and more sensitive to depolarization, important in denervation or burn injuries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do NMBAs primarily act?

A

At the neuromuscular junction for muscle relaxation and at autonomic ganglia/CNS for potential off-target effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a competitive (non-depolarizing) block?

A

A competitive block reversibly competes with acetylcholine. Typical agents include rocuronium and vecuronium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens during a non-competitive (depolarizing) block - Phase I?

A

Succinylcholine mimics acetylcholine and binds irreversibly at first, causing initial fasciculations followed by flaccid paralysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Phase II block?

A

Occurs with high or repeated doses of succinylcholine and clinically mimics non-depolarizing block. It is reversible with acetylcholinesterase inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is desensitization block?

A

The receptor is occupied but unresponsive to acetylcholine, triggered by excess agonists, AChE inhibitors, or multiple drug classes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the critical concept of channel block?

A

Non-competitive block of ACh receptor channel prevents opening/closing and is irreversible by AChE inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical takeaways regarding Phase II and channel blocks?

A

Phase II and channel blocks mimic non-depolarizers with TOF fade and tetany without sustained response. Only Phase II block responds to reversal agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the role of acetylcholinesterase?

A

It hydrolyzes acetylcholine at the neuromuscular junction into choline and acetic acid, and is involved in managing bradycardia and salivation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the structure-activity relationships of NMBAs?

A

All NMBAs have at least one quaternary amine, limiting CNS penetration. Most have two amine groups, affecting their risk for histamine release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the mechanisms of histamine release?

A

Histamine release can be IgE-mediated (true anaphylaxis), IgG/IgM mediated (complement activation), or through direct mast cell degranulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can histamine-mediated effects be prevented?

A

Slower or titrated dosing decreases release, and premedication with H1 or H2 blockers can be used.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the pharmacologic variables of NMBAs?

A

ED₉₅/ED₅₀ indicates the dose required to block twitch response. Onset time varies between agents, with rocuronium being fast and vecuronium slower.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the preferred route of administration for NMBAs?

A

IV route is preferred for rapid onset and predictable distribution; IM/SQ is less predictable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What factors influence pharmacokinetics of NMBAs?

A

Factors include quaternary ammonium structure, protein binding, receptor affinity, injection speed, perfusion, obesity, and age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the clinical implications of pregnancy on NMBA use?

A

Pregnancy increases potency and duration with magnesium sulfate, but NMBAs have minimal placental transfer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the metabolism of succinylcholine?

A

Succinylcholine is rapidly metabolized by plasma cholinesterase, with a typical onset of 20-40 seconds and duration of 5-10 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the absolute contraindications for succinylcholine?

A

Contraindications include hyperkalemia risk, malignant hyperthermia susceptibility, allergy to succinylcholine, and homozygous atypical plasma cholinesterase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What cardiovascular side effects can succinylcholine cause?

A

It may cause bradycardia, idioventricular rhythms, and ventricular arrhythmias, especially in pediatrics or with vagal stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the characteristics of non-depolarizing NMBAs?

A

They are classified into benzylisoquinolines and aminosteroids, with varying durations of action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the onset and duration of rocuronium?

A

Rocuronium has an onset of 1-1.5 minutes and a duration of 35-50 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the caution associated with mivacurium?

A

Mivacurium is hydrolyzed by plasma cholinesterase, so caution is advised in cases of deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the class of succinylcholine?

A

Aminosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the onset time for succinylcholine?
1–1.5 minutes (fastest of all non-depolarizers)
26
What is the duration of succinylcholine?
35–50 minutes
27
What is the ideal alternative to succinylcholine for RSI?
Rocuronium (at high dose ~1.2 mg/kg)
28
What is the class of Atracurium?
Benzylisoquinoline
29
What is the onset time for Atracurium?
2–3 minutes
30
What is the duration of Atracurium?
35–50 minutes
31
How is Atracurium metabolized?
Hoffman elimination + ester hydrolysis
32
What caution is associated with Atracurium?
Histamine release
33
What is the class of Cisatracurium?
Benzylisoquinoline
34
What is the onset time for Cisatracurium?
3–6 minutes
35
What is the duration of Cisatracurium?
40–55 minutes
36
How is Cisatracurium metabolized?
Hoffman elimination
37
What is an advantage of Cisatracurium?
Minimal histamine, preferred in ICU/organ failure
38
What is the class of Pancuronium?
Aminosteroid
39
What is the onset time for Pancuronium?
3.5–6 minutes
40
What is the duration of Pancuronium?
70–120 minutes
41
How is Pancuronium metabolized?
Renal and hepatic
42
What are the side effects of Pancuronium?
Vagolytic → ↑ HR, ↑ BP
43
What is the clinical application of RSI?
Requires onset <60–90 seconds to avoid aspiration.
44
Which agent reliably meets the onset window for RSI?
Succinylcholine
45
What is the priming technique for RSI?
Administer small dose ~3 minutes before full intubating dose.
46
What is a drawback of non-depolarizing NMBAs?
Longer onset than succinylcholine.
47
What are additional uses for NMBAs?
Part of balanced anesthesia and ICU sedation adjunct.
48
What is the mechanism of reversal agents?
Inhibit acetylcholinesterase → ↑ acetylcholine at NMJ → competes with NMBA.
49
What is the dosing for Pyridostigmine?
0.25 mg/kg
50
What is the dosing for Neostigmine?
0.03–0.06 mg/kg (most common)
51
What is the dosing for Edrophonium?
0.5–1 mg/kg (rapid onset, shorter duration)
52
What is required when using Neostigmine?
Co-administration of an antimuscarinic (e.g., glycopyrrolate or atropine).
53
What is the preferred reversal agent for rocuronium/vecuronium?
Sugammadex
54
What is the indication for Sugammadex?
Reversal of aminosteroid NMBAs: rocuronium and vecuronium only.
55
What is the mechanism of Sugammadex?
Encapsulates free NMBA molecules, inactivating them.
56
What is the dosing for moderate block with Sugammadex?
2 mg/kg
57
What is the dosing for deep block with Sugammadex?
4 mg/kg
58
What is the dosing for emergent reversal with Sugammadex?
16 mg/kg within 3 mins of 1.2 mg/kg rocuronium.
59
What are the adverse events of Sugammadex?
Hypersensitivity reactions, increased aPTT, marked bradycardia.
60
What is a clinical pearl regarding Sugammadex?
Preferred for rapid reversal of high-dose rocuronium.
61
What are the considerations for renal insufficiency with NMBAs?
Prolonged NMBA and reversal agent action → close monitoring required.
62
What are the considerations for liver insufficiency with NMBAs?
Prolonged NMBA duration due to decreased hepatic clearance.
63
What is upregulation of ACh receptors?
Triggered by loss of neural input, leading to increased sensitivity.
64
What are causes of upregulation?
Denervation, immobilization, burns, sepsis.
65
What is the risk associated with succinylcholine in upregulated patients?
Exaggerated K⁺ efflux → life-threatening hyperkalemia.
66
What is the pathophysiology of Myasthenia Gravis?
Autoimmune destruction of nicotinic ACh receptors.
67
What are the clinical signs of Myasthenia Gravis?
Ptosis, diplopia, bulbar symptoms, weakness.
68
What is the treatment for Myasthenia Gravis?
Cholinesterase inhibitors (e.g., pyridostigmine).
69
What is the pathophysiology of Lambert-Eaton Myasthenic Syndrome?
Autoantibodies against presynaptic calcium channels.
70
What is the NMBA sensitivity in LEMS?
Increased sensitivity to both depolarizing and non-depolarizing agents.
71
What is the TOF response in LEMS?
Enhancement with repeated stimulation.
72
What are the pharmacokinetic interactions with NMBAs?
↓ Cardiac output → delayed NMBA onset.
73
What are junctional interactions affecting ACh release?
Furosemide, volatile anesthetics, magnesium, CCBs, aminoglycosides.
74
What is a clinical implication of combining NMBAs with certain agents?
Prolonged or potentiated blockade.
75
What should be assessed before attempting reversal of NMBA?
Train-of-Four (TOF)
76
What is the critical concern with residual neuromuscular block?
Recurarization is possible if reversal agent half-life is shorter.
77
What is the management for prolonged paralysis due to pseudocholinesterase deficiency?
Mechanical ventilation until spontaneous recovery.
78
What is the purpose of Rapid Sequence Intubation (RSI)?
Prevent aspiration by securing airway as quickly as possible.
79
What is the preferred agent for RSI?
Succinylcholine
80
What are the side effects of succinylcholine?
Myalgias, bradycardia
81
What is a fasciculation prevention strategy?
Pre-curarization: small dose of non-depolarizing NMBA.
82
What should be done if fasciculation prevention is used?
↑ succinylcholine dose by 25–75%.
83
What is pre-curarization?
A small dose of non-depolarizing NMBA (e.g., 1/10th intubating dose).
84
What is self-taming succinylcholine?
Fractionated dosing of succinylcholine.
85
What adjuncts can be used with NMBA?
Lidocaine and opioids.
86
How should succinylcholine dose be adjusted if fasciculation prevention is used?
Increase the succinylcholine dose by 25–75% to maintain effective onset and depth of block.
87
What are the uses of sustained blockade in the critically ill?
To facilitate mechanical ventilation, treat muscle spasm (e.g., tetanus), and decrease oxygen consumption in head trauma, ARDS, or metabolic crisis.
88
What should be monitored during sustained blockade?
Closely monitor to avoid prolonged paralysis, critical illness polyneuromyopathy, and residual blockade.
89
What is a major downside of sustained blockade?
Prolonged weakness and potential for critical illness polyneuromyopathy.
90
What is mandatory when using NMBA?
Adequate sedation and analgesia; never paralyze an awake patient!
91
What is recommended to prevent overtreatment during NMBA therapy?
TOF monitoring and daily interruption of NMBA therapy.
92
What are commonly used NMBA agents?
Pancuronium (long-acting, vagolytic), Vecuronium (intermediate-acting, steroidal, hepatically cleared), and Cisatracurium (intermediate-acting, organ-independent Hoffman elimination, preferred in multi-organ failure).
93
What supportive measures should be taken during paralysis?
Eye care (to prevent corneal abrasions), physical therapy (to mitigate muscle atrophy), and DVT prophylaxis (heparin, SCDs) due to immobility.
94
What is a clinical pearl regarding paralysis?
Paralysis without sedation is unethical and dangerous; always ensure deep sedation first.
95
Why is Cisatracurium preferred for sustained blockade in ICU?
Due to predictable elimination and safety in organ failure.